Seven years ago, Rachel Haurwitz finished her last day as a student in the University of California laboratory where she helped conduct some of the pioneering research on the gene editing technology k
CRISPR, the gene-editing system that could one day change the course of humanity still has a long way to go before we seriously alter anything but it’s not too far-fetched to say it could happen
Caribou Bioscience co-founder and CEO Rachel Haurwitz joined us onstage at Disrupt this morning to help unpack some of the myriad complexities around her company’s pioneering work in the field of CR
CRISPR Cas9, the framework to program and edit our genetic code, has been hailed as the technological discovery of the century. It holds great promise for improving our food supply and wiping out canc